Abstract
Dihydroartemisinin, formerly known as an antimalarial drug, is the main metabolite of the mother compound artemisinins, as well as of artemether and artesunate. It has been shown that the drug exhibits antischistosomal efficacy against Schistosoma japonicum. The purpose of the current study was to assess the in vivo effect of dihydroartemisinin against Schistosoma mansoni infection in mice. Drugs at a single oral dose of 300 mg/kg were given to mice to assess the efficacy against different developmental stages of the parasite; juvenile and adult S. mansoni were treated with single doses of dihydroarteminisin with different regimens (at 200, 300, 400 or 600 mg/kg) in the stage of drug sensitivity, and the dose–response relationship was assessed; and the effect of multiple doses (at 200, 300 or 400 mg/kg) on juvenile and adult S. mansoni was also observed. The results showed that a single oral dose (300 mg/kg) of dihydroartemisinin reduced total worm burdens by 13.8–82.1% and female worm burdens by 13–82.8%, and the greatest reductions were seen when treatment was given on day 21 post-infection, with total and female worm burden reductions of 82.1% and 82.8%. Administration of a single oral dose of dihydroartemisinin on day 21 post-infection with different drug dosage (at 200, 300, 400 or 600 mg/kg) reduced total worm burdens by 70.3–87.3% and female worm burdens by 73.5–92.4%, depending on dosage. Similar treatments given on day 49 post-infection reduced total worm burdens by 48.7–68.73% and female worm burdens by 63.25–94.6%. There was obvious dose–response relationship of dihydroartemisinin against the schistosomula and adult worms of S. mansoni observed. Administration with dihydroartemisinin at oral doses of 200, 300 and 400 mg/kg, given once on each of days 20–22 post-infection of three successive days, reduced total worm burdens by 88.5–90.1% and female worm burdens by 89.2–92.1%, depending on dosage. Similar treatments given once on each of days 48–50 post-infection reduced total worm burdens by 60–70.3% and female worm burdens by 77.5–94.9%. It is concluded that dihydroartemisinin exhibits in vivo activity against various developmental stages of S. mansoni, particularly the 21-day schistosomula, and there is obvious dose–response relationship of dihydroartemisinin against the schistosomula and adult worms of S. mansoni observed.
Similar content being viewed by others
References
Abdul-Ghani RA, Loutfy N, Hassan A (2009) Experimentally promising antischistosomal drugs: a review of some drug candidates not reaching the clinical use. Parasitol Res 105:899–906
Abdul-Ghani RA, Loutfy N, Sheta M, Hassan A (2011) Artemether shows promising female schistosomicidal and ovicidal effects on the Egyptian strain of Schistosoma mansoni after maturity of infection. Parasitol Res 108:1199–1205
Cioli D (1998) Chemotherapy of schistosomiasis: an update. Parasitol Today 14:418–422
Cioli D (2000) Praziquantel: is there real resistance and are there alternatives? Curr Opin Infect Dis 13:659–663
Cioli D, Pica-Mattoccia L (2003) Praziquantel. Parasitol Res 90:S3–S9
Cioli D, Valle C, Angelucci F, Miele AE (2008) Will new antischistosomal drugs finally emerge? Trends Parasitol 24:379–382
Fallon PG, Doenhoff MJ (1994) Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am J Trop Med Hyg 51:83–88
Fallon PG, Sturrock RF, Niang AC, Doenhoff MJ (1995) Diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. Am J Trop Med Hyg 53:61–62
Gönnert R, Andrews P (1977) Praziquantel, a new board-spectrum antischistosomal agent. Z Parasitenkd 52:129–150
Hanallah S, EL-Lakkany N, Mahmoud S, Mousa M, Botros S (2003) Altered immunoglobulin isotype profile and anti-immature worm surface immunoglobulins in mice harboring a praziquantel-resistant Schistosoma mansoni isolate. APMIS 111:1125–1132
Haynes RK, Chan WC, Wong HN, Li KY, Wu WK, Fan KM, Sung HH, Williams ID, Prosperi D, Melato S, Coqhi P, Monti D (2010) Facile oxidation of leucomethylene blue and dihydroflavins by artemisinins: relationship with flavoenzyme function and antimalarial mechanism of action. ChemMedChem 5:1282–1299
Ismail M, Metwally A, Farghaly A, Bruce J, Tao LF, Bennett JL (1996) Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high dose of praziquantel. Am J Trop Med Hyg 55:214–218
Ismail M, Botros S, Metwally A, William S, Farghally A, Tao LF, Day TA, Bennett JL (1999) Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am J Trop Med Hyg 60:932–935
Li HJ, Wang W, Li YZ, Qu GL, Xing YT, Tao YH, Wei JY, Dai JR, Liang YS (2011a) Effects of artemether, artesunate and dihydroartemisinin administered orally at multiple doses or combination in treatment of mice infected with Schistosoma japonicum. Parasitol Res 109:515–519
Li HJ, Wang W, Qu GL, Tao YH, Xing YT, Li YZ, Wei JY, Dai JR, Liang YS (2011b) In vivo activity of dihydroartemisinin against Schistosoma japonicum. Ann Trop Med Parasitol 105:181–185
Li HJ, Wang W, Qu GL, Tao YH, Xing YT, Li YZ, Wei JY, Dai JR, Liang YS (2011c) Dihydroartemisinin–praziquantel combinations and multiple doses of dihydroartemisinin in the treatment of Schistosoma japonicum in experimentally infected mice. Ann Trop Med Parasitol 105:329–333
Magalhães LG, Machado CB, Morais ER, Moreira EB, Soares CS, da Silva SH, Da Silva Filho AA, Rodrigues V (2009) In vitro schistosomicidal activity of curcumin against Schistosoma mansoni adult worms. Parasitol Res 104:1197–1201
Magalhães LG, Kapadia GJ, da Silva Tonuci LR, Caixeta SC, Parreira NA, Rodrigues V, Da Silva Filho AA (2010) In vitro schistosomicidal effects of some phloroglucinol derivatives from Dryopteris species against Schistosoma mansoni adult worms. Parasitol Res 106:395–401
Melman SD, Steinauer ML, Cunningham C, Kubatko LS, Mwangi IN, Wynn NB, Mutuku MW, Karanja DM, Colley DG, Black CL, Secor WE, Mkoji GM, Loker ES (2009) Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl Trop Dis 3:e504
Meshnick SR, Tsang TW, Lin FB, Pan HZ, Chang CN, Kuypers F, Chiu D, Lubin B (1989) Activated oxygen mediates the antimalarial activity of qinghaosu. Prog Clin Biol Res 313:95–104
Meshnick SR, Taylor TE, Kamchonwongpaisan S (1996) Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol Rev 60:301–315
Sabah AA, Fletcher C, Webbe G, Doenhoff MJ (1986) Schistosoma mansoni: chemotherapy of infections of different ages. Exp Parasitol 61:294–303
Seubert J, Pohlke R, Loebich F (1977) Synthesis and properties of praziquantel, a novel broad spectrum anthelmintic with excellent activity against schistosomes and cestodes. Experientia 33:1036–1037
Shaohong L, Kumagai T, Qinghua A, Xiaolan Y, Ohmae H, Yabu Y, Siwen L, Liyong W, Maruyama H, Ohta N (2006) Evaluation of the anthelmintic effects of artesunate against experimental Schistosoma mansoni infection in mice using different treatment protocols. Parasitol Int 55:63–68
Smithers SR, Terry RJ (1965) The infection of laboratory hosts with cercariae of Schistosoma mansoni and recovery of adult worms. Parasitology 55:695–700
Stelma FF, Talla I, Sow S, Kongs A, Niang M, Polman K, Deelder AM, Gryseeks B (1995) Efficacy and side effects of praziquantel in an epidemic focus of Scistosoma mansoni. Am J Trop Med Hyg 53:167–170
Tu YY (2009) Artemisia annua and artemisinin drugs. Chemical Industry, Beijing
Utzinger J, N’Goran EK, N’Dri A, Lengeler C, Xiao SH, Tanner M (2000) Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet 355:1320–1325
Utzinger J, Chollet J, You J, Mei J, Tanner M, Xiao SH (2001) Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals. Acta Trop 80:9–18
Utzinger J, Chollet J, Tu Z, Xiao SH, Tanner M (2002) Comparative study of the effects of artemether and artesunate on juvenile and adult Schistosoma mansoni in experimentally infected mice. Trans R Soc Trop Med Hyg 96:318–323
Wang W, Dai JR, Li HJ, Shen XH, Liang YS (2010) Is there reduced susceptibility to praziquantel in Schistosoma japonicum? Evidence from China. Parasitology 137:1905–1912
WHO (2002) Controlling disease due to helminth infections. WHO Technical Report Series No. 912. Geneva
William S, Sabra A, Ramzy F, Mousa M, Demerdash Z, Bennett JL, Day TA, Botros S (2001) Stability and reproductive fitness of Schistosoma mansoni isolates with decreased sensitivity to praziquantel. Int J Parasitol 31:1093–1100
Xiao SH, Yue WJ, Yang YQ, You JQ (1987) Susceptibility of Schistosoma japonicum of different developmental stages to praziquantel. Chin Med J (Engl) 100:759–768
Xiao SH, You JQ, Wang CZ (1995) Experimental studies on early treatment of schistosomal infection with artemether. Southeast Asia J Trop Med Public Health 26:306–308
Xiao SH, Chollet J, Weiss NA, Bergquist RN, Tanner M (2000a) Preventive effect of artemether in experimental animals infected with Schistosoma mansoni. Parasitol Int 49:19–24
Xiao SH, Booth M, Tanner M (2000b) The prophylactic effects of artemether against Schistosoma japonicum infections. Parasitol Today 16:122–126
Xiao SH, Tanner M, N’Goran EK, Utzinger J, Chollet J, Bergquist R, Chen M, Zheng J (2002a) Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Trop 82:175–181
Xiao SH, You JQ, Gao HF et al (2002b) Schistosoma japonicum: effect of artemether on glutathione S-transferase and superoxide dismutase. Exp Parasitol 102:38–45
Xiao SH, Wu YL, Tanner M, Wu WM, Utizinger J, Mei JY, Scorneaux B, Chollet J, Zhai ZL (2003) Schistosoma japonicum: in vitro effects of artemether combined with haemin depend on cultivation media and appraisal of artemether products appearing in the media. Parasitol Res 89:459–466
Xiao SH, Utzinger J, Chollet J, Tanner M (2006) Effect of artemether administered alone or in combination with praziquantel to mice infected with Plasmodium berghei or Schistosoma mansoni or both. Int J Parasitol 36:957–964
Xiao SH, Mei JY, Jiao PY (2009) The in vitro effect of mefloquine and praziquantel against juvenile and adult Schistosoma japonicum. Parasitol Res 106:237–246
Zhai ZL, Jiao PY, Mei JY, Xiao SH (2002) Glutathione inhibits the antischistosomal activity of artemether. Chin J Parasitol Parasit Dis 20:212–215
Acknowledgements
This study received financial support from the National Science and Technology Pillar Program of China (grant no. 2009BAI78B06), Jiangsu Department of Health (grants no. X200911 and X200912) and Jiangsu Preventive Medicine Association (grant no. Y201031). The experiments in this study are in compliance with the current laws and regulations of China.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, Hj., Wang, W., Qu, Gl. et al. Effect of the in vivo activity of dihydroartemisinin against Schistosoma mansoni infection in mice. Parasitol Res 110, 1727–1732 (2012). https://doi.org/10.1007/s00436-011-2692-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-011-2692-x